[Federal Register Volume 85, Number 97 (Tuesday, May 19, 2020)]
[Notices]
[Pages 29978-29979]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10734]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-647]
Importer of Controlled Substances Application: Biopharmaceutical
Research Company LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
[[Page 29979]]
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before June 18, 2020.
Such persons may also file a written request for a hearing on the
application on or before June 18, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on December 21, 2018, Biopharmaceutical Research Company
LLC, 11045 Commercial Parkway, Castroville, California 95012-3209,
applied to be registered as an importer of the following basic
class(es) of controlled substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marijuana.............................. 7360 I
------------------------------------------------------------------------
The company plans to import narcotic raw material for bulk
manufacture and analytical purposes. This notice does not constitute an
evaluation or determination of the merits of the company's application.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-10734 Filed 5-18-20; 8:45 am]
BILLING CODE 4410-09-P